Synapse - Center for Hematologic Malignancies

Results (13553)

Transplantation of peripheral blood progenitor cells (PBPC) as compared to bone marrow (BM) from unrelated related donors for hematologic cancers using fludarabine-alkylating agent based reduced intensity conditioning regimens

Meeting Abstract

Eapen, M.; Logan, B. R.; Horowitz, M. M.; Zhong, X.; Perales, M. A.; Lee, S. J.; Rocha, V.; Soiffer, R. J.; Weisdorf, D. J.; Champlin, R. E.
Blood (2013)

Fulltext@MSK | Save

Preliminary safety and efficacy of IPI-145, a potent inhibitor of phosphoinositide-3-kinase-δ,γ, in patients with chronic lymphocytic leukemia

Meeting Abstract

Flinn, I.; Patel, M.; Kahl, B. S.; Horwitz, S. M.; Foss, F. M.; Oki, Y.; Porcu, P.; Sweeney, J.; Allen, K.; Faia, K.; more...
Blood (2013)

Fulltext@MSK | Save

Eomesodermin regulates the early activation of alloreactive CD4 T cells and is critical for both Gvh and GVL responses

Meeting Abstract

Du Rocher, B.; Smith, O. M.; Intlekofer, A. M.; Dudakov, J. A.; Levy, E.; Kreiners, F.; Reiner, S.; Abdelhay, E.; van den Brink, M. R. M.; Hanash, A. M.
Blood (2013)

Fulltext@MSK | Save

Intrathymic innate lymphoid cells: Long-lived mediators of immune regeneration

Meeting Abstract

Dudakov, J. A.; Cole, D.; Hanash, A. M.; Young, L. F.; Kreines, F. M.; Levy, E. R.; Smith, O. M.; Velardi, E.; van den Brink, M.
Blood (2013)

Fulltext@MSK | Save

Treatment with the potent PI3K-,δ,γ inhibitor IPI-145 is associated with rapid decreases in specific cytokines, chemokines and matrix metalloproteinases in the serum of patients with chronic lymphocytic leukemia and indolent non-Hodgkin lymphoma

Meeting Abstract

Douglas, M.; Allison, K.; Ted, S.; Allen, K.; Kahl, B. S.; Horwitz, S. M.; Flinn, I. W.; Kelly, P.; Stern, H. M.
Blood (2013)

Fulltext@MSK | Save

Therapeutic efficacy and cure of sensitive and T315I pan-resistant human Ph+ leukemia in mice using a TCR-like antibody to WT1/HLA-A0201 alone, or in combination with tyrosine kinase inhibitors

Meeting Abstract

Dubrovsky, L.; Brea, E.; Pankov, D.; Veomett, N.; Dao, T.; Yan, S.; Liu, C.; Scheinberg, D. A.
Blood (2013)

Fulltext@MSK | Save

Prospective evaluation of alternative donor availability in 708 patients: Improved allograft access with enlarging CB inventory for all patients including racial and ethnic minorities

Meeting Abstract

Dahi, P. B.; Ponce, D. M.; Byam, C.; Devlin, S.; Lubin, M. N.; Evans, K. L.; Gonzales, A. M. R.; Sideroff, M.; Wells, D.; Giralt, S. A.; more...
Blood (2013)

Fulltext@MSK | Save

High-dose cytarabine monotherapy versus intermediate or high-dose cytarabine in combination with other agents as second-line salvage therapy In patients with acute myeloid leukemia who did not respond to initial induction therapy

Meeting Abstract

Dang, T. O. T.; Hilden, P.; Devlin, S. M.; Rampal, R. K.; Levine, R. L.; Berman, E.; Klimek, V. M.; Adel, N. G.; Tallman, M. S.
Blood (2013)

Fulltext@MSK | Save

Safe and effective re-induction of complete remissions in adults with relapsed B-ALL using 19-28z CAR CD19-targeted T cell therapy

Meeting Abstract

Davila, M. L.; Riviere, I.; Wang, X.; Bartido, S.; Stefanski, J.; He, Q.; Borquez-Ojeda, O.; Taylor, C.; Wasielewska, T.; Qu, J.; more...
Blood (2013)

Fulltext@MSK | Save

MAGE-A3 recombinant protein (recMAGE-A3) immunotherapy and autologous peripheral blood lymphocyte (PBL) infusion is safe and induces robust humoral immune responses in multiple myeloma (MM) patients undergoing autologous stem cell transplantation (autoSCT)

Meeting Abstract

Cohen, A. D.; Lendvai, N.; Gnjatic, S.; Jungbluth, A. A.; Bertolini, S.; Pan, L.; Venhaus, R.; Tsakos, I.; Garcia, K.; Thibodeau, L.; more...
Blood (2013)

Fulltext@MSK | Save